Esperion Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2017 Financial Results ANN ARBOR, Mich., May 04, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary,...